Showing 10,501 - 10,520 results of 226,405 for search '(( a ((((a decrease) OR (greater decrease))) OR (linear decrease)) ) OR ( a largest decrease ))', query time: 1.95s Refine Results
  1. 10501

    Data Sheet 3_Mechanistic study of the hsa_circ_0074158 binding EIF4A3 impairing sepsis-induced endothelial barrier.zip by Haiyan Liao (6100043)

    Published 2025
    “…Mechanistically, RNA pull-down and RNA RIP assays demonstrated that hsa_circ_0074158 directly binds to the RNA-binding protein (RBP) EIF4A3, which decreases the stability of CTNNA1 (mRNA) and the production of α-catenin, subsequently impairing endothelial barrier function in sepsis. …”
  2. 10502

    Table 1_Mechanistic study of the hsa_circ_0074158 binding EIF4A3 impairing sepsis-induced endothelial barrier.xlsx by Haiyan Liao (6100043)

    Published 2025
    “…Mechanistically, RNA pull-down and RNA RIP assays demonstrated that hsa_circ_0074158 directly binds to the RNA-binding protein (RBP) EIF4A3, which decreases the stability of CTNNA1 (mRNA) and the production of α-catenin, subsequently impairing endothelial barrier function in sepsis. …”
  3. 10503

    Data Sheet 2_Mechanistic study of the hsa_circ_0074158 binding EIF4A3 impairing sepsis-induced endothelial barrier.zip by Haiyan Liao (6100043)

    Published 2025
    “…Mechanistically, RNA pull-down and RNA RIP assays demonstrated that hsa_circ_0074158 directly binds to the RNA-binding protein (RBP) EIF4A3, which decreases the stability of CTNNA1 (mRNA) and the production of α-catenin, subsequently impairing endothelial barrier function in sepsis. …”
  4. 10504

    Image 1_Mechanistic study of the hsa_circ_0074158 binding EIF4A3 impairing sepsis-induced endothelial barrier.tif by Haiyan Liao (6100043)

    Published 2025
    “…Mechanistically, RNA pull-down and RNA RIP assays demonstrated that hsa_circ_0074158 directly binds to the RNA-binding protein (RBP) EIF4A3, which decreases the stability of CTNNA1 (mRNA) and the production of α-catenin, subsequently impairing endothelial barrier function in sepsis. …”
  5. 10505

    Data Sheet 4_Mechanistic study of the hsa_circ_0074158 binding EIF4A3 impairing sepsis-induced endothelial barrier.zip by Haiyan Liao (6100043)

    Published 2025
    “…Mechanistically, RNA pull-down and RNA RIP assays demonstrated that hsa_circ_0074158 directly binds to the RNA-binding protein (RBP) EIF4A3, which decreases the stability of CTNNA1 (mRNA) and the production of α-catenin, subsequently impairing endothelial barrier function in sepsis. …”
  6. 10506

    Data Sheet 5_Mechanistic study of the hsa_circ_0074158 binding EIF4A3 impairing sepsis-induced endothelial barrier.zip by Haiyan Liao (6100043)

    Published 2025
    “…Mechanistically, RNA pull-down and RNA RIP assays demonstrated that hsa_circ_0074158 directly binds to the RNA-binding protein (RBP) EIF4A3, which decreases the stability of CTNNA1 (mRNA) and the production of α-catenin, subsequently impairing endothelial barrier function in sepsis. …”
  7. 10507

    The Δ15N deletion abolished A3H HapII anti-viral activity and virion incorporation. by Anjie Zhen (313428)

    Published 2013
    “…<p>To compare anti-viral activity and packaging of A3H HapII and HapIIΔ15N, pNL4–3Δvif was transfected with decreasing doses of A3H HapII and HapIIΔ15N. …”
  8. 10508

    Comparison of healthy controls to hyperthyroid state. by Molly A. Bechtold (18794251)

    Published 2024
    “…Metabolites significantly (<i>P</i> < 0.05) increased (red) or decreased (blue) greater than 2-fold are depicted by single dots. …”
  9. 10509

    The perturbed expression of m6A in parthenogenetic mouse embryos by Jindong Hao (8045717)

    Published 2019
    “…Furthermore, immunofluorescence was used to detect m6A expression. The results demonstrated that m6A expression decreased in the 2-cell stage, whereas it increased in the 8-cell stage of PA embryos. …”
  10. 10510

    Nakasone. AJP supple Table1, 2, 3 by Toru Aizawa (9001298)

    Published 2023
    “…Note that <em>increased</em> eGFR is a protective factor so that risk from <em>decreased </em>eGFR can be obtained by calculating reciprocal of the listed HR.…”
  11. 10511

    Novelty and Primacy: A Long-Term Estimator for Online Experiments by Soheil Sadeghi (1538746)

    Published 2023
    “…However, since experiments are typically limited in duration, observed treatment effects are not always stable, sometimes revealing increasing or decreasing patterns over time. There are multiple causes for a treatment effect to change over time. …”
  12. 10512

    Data_Sheet_1_Antibacterial and anti-biofilm activity of diarylureas against Enterococcus faecium by suppressing the gene expression of peptidoglycan hydrolases and adherence.PDF by Yunfeng Xie (11437128)

    Published 2022
    “…Moreover, ZJ-2 can be docked into SagA to inhibit daughter cell separation. In a mouse model of abdominal infection, ZJ-2 decreased the bacterial load and the level of IL-6 and TNF-α in a time-dependent manner. …”
  13. 10513

    Evaluating competitive inhibition by gcn5-F221A using a synthetic pPHO5-yECitrine construct. by Amanda M. Lanza (168454)

    Published 2012
    “…Increasing expression of <i>gcn5-F221A</i> resulted in decreased mean fluorescence. …”
  14. 10514

    MiR-27a Functions as a Tumor Suppressor in Acute Leukemia by Regulating 14-3-3θ by Kara A. Scheibner (113934)

    Published 2012
    “…Decreased miR-23a cluster expression in some acute leukemia cell lines was mediated by c-MYC. …”
  15. 10515

    Image_5_LaeA Controls Virulence and Secondary Metabolism in Apple Canker Pathogen Valsa mali.TIF by Yaqiong Feng (9604034)

    Published 2020
    “…Toxicity tests proved that toxicity of secondary metabolites (SMs) produced by VmLaeA deletion mutant (ΔVmlaeA) was markedly decreased in comparison with wild-type (WT). …”
  16. 10516

    Image 3_A novel dual DYRK1A/B inhibitor for the treatment of type 1 diabetes.jpeg by Šarūnas Tumas (22419055)

    Published 2025
    “…</p>Results<p>Pharmacokinetic analysis confirmed the oral bioavailability of FX8474, and treatment was associated with improved fasted glucose levels and glucose tolerance after a 7-day treatment. Immunophenotyping indicated that FX8474 treatment increases CD4+ memory T cell populations while decreasing CD4+ effector cells, as well as restores CD8+ T cell phenotypes to levels observed in healthy mice.…”
  17. 10517

    Image_4_LaeA Controls Virulence and Secondary Metabolism in Apple Canker Pathogen Valsa mali.TIF by Yaqiong Feng (9604034)

    Published 2020
    “…Toxicity tests proved that toxicity of secondary metabolites (SMs) produced by VmLaeA deletion mutant (ΔVmlaeA) was markedly decreased in comparison with wild-type (WT). …”
  18. 10518

    Image 5_A novel dual DYRK1A/B inhibitor for the treatment of type 1 diabetes.jpeg by Šarūnas Tumas (22419055)

    Published 2025
    “…</p>Results<p>Pharmacokinetic analysis confirmed the oral bioavailability of FX8474, and treatment was associated with improved fasted glucose levels and glucose tolerance after a 7-day treatment. Immunophenotyping indicated that FX8474 treatment increases CD4+ memory T cell populations while decreasing CD4+ effector cells, as well as restores CD8+ T cell phenotypes to levels observed in healthy mice.…”
  19. 10519

    Image_7_LaeA Controls Virulence and Secondary Metabolism in Apple Canker Pathogen Valsa mali.TIF by Yaqiong Feng (9604034)

    Published 2020
    “…Toxicity tests proved that toxicity of secondary metabolites (SMs) produced by VmLaeA deletion mutant (ΔVmlaeA) was markedly decreased in comparison with wild-type (WT). …”
  20. 10520

    Data_Sheet_1_Major primary bile salts repress Salmonella enterica serovar Typhimurium invasiveness partly via the efflux regulatory locus ramRA.PDF by Etienne Giraud (122065)

    Published 2024
    “…Previous studies reported that bile inhibits the RamR binding to the ramA promoter, resulting in ramA increased transcription, and that ramA overexpression is associated to decreased expression of type III secretion system 1 (TTSS-1) invasion genes and to impaired intestinal cell invasiveness in S. …”